Ex-Illinois House Speaker Michael Madigan Asks Trump For Pardon Effingham Legislative Committee Met Monday Transportation Committee Met Wednesday Local Sports Results For Friday Help The Effingham Public Library Fill Its Community Cabinet Effingham County Warming Options Available If Needed During Cold Weather Local Sports Schedule For Saturday Holiday Lights & Festive Sights Tour: Time To Vote Friday Police Blotter More Snow Expected Saturday, Below Zero Low Temperatures For Weekend Lake Land College Receives IGEN Membership Grant For Campus Lighting Closings and Cancellations For December 12th Local Sports Schedule For Friday Local Sports Results For Thursday Two Vehicle Accident With Injuries In Mound Township City Of St. Peter Issues Boil Order For Select Streets National Weather Service Shares Tips To Help Prepare For Cold Weather Four Effingham Firefighters Complete Illinois Fire Service Institute Fire Academy Thursday Police Blotter Winter Weather Advisory Issued As Snow Likely This Afternoon Into Tonight, Extreme Cold Over Weekend

FDA Hims And Hers Misleading Claims Warning

Effingham, IL / Effingham Radio

Sep 17, 2025 | 6:00 PM

Washington, DC-(Effingham Radio)- The FDA is issuing a warning letter to the telehealth firm Hims and Hers Health.

According to the FDA, after a review of the Hims’ website it was found that the company was making false or misleading claims about its compounded semaglutide products, which is the active ingredient in Ozempic and Wegovy.

The warning comes just months after Novo Nordisk terminated its collaboration with Hims and Hers, citing illegal mass compounding and deceptive marketing practices. The FDA has given the company 15 working days to respond with specific steps taken to address the violations.

Copyright © 2025 TTWN Media Networks Inc.

Download the free Effingham Radio app for music, news, contests and more!

Comments

Leave a Reply Cancel reply

You must be logged in to post a comment.